RESCON Summit 2025 is the leading strategic event for senior executives driving innovation in inhalation and respiratory drug delivery. Taking place on November 5–6, 2025, in San Francisco, the summit brings together global leaders from pharma, biotech, and device industries to explore the latest trends, technologies, and business strategies shaping the future of inhaled therapeutics.
This year’s program focuses on high-impact innovations across the full development spectrum — from small molecules and LNPs to smart inhalers, AI-powered design, and digital health integration. With a strong emphasis on commercial viability, regulatory navigation, and partnership building, RESCON Summit 2025 is designed for decision-makers seeking actionable insights and meaningful connections in this rapidly evolving field.
1. Innovations in Inhaled Formulations
Explore small molecules, biologics, LNPs, and mRNA approaches driving next-generation inhaled therapies for respiratory and systemic delivery.
2. Smart Inhalers & Connected Devices
Learn how design, usability testing, and integrated data solutions improve adherence, enable remote monitoring, and support value-based healthcare models.
3. Advanced Particle Engineering
Understand micronization, morphology control, and carrier selection to optimize lung deposition, stability, and bioavailability of inhaled APIs.
4. Sustainable & Patient-Centric Design
Examine low-GWP propellants, recyclable materials, and human factors studies that deliver greener, intuitive, and accessible inhaler solutions.
5. Analytical & Stability Challenges
Gain insights into extractables, leachables, performance testing, and packaging strategies ensuring safety, efficacy, and long shelf-life.
6. Manufacturing & Supply Chain Solutions
Discover scalable continuous manufacturing, cold chain logistics, and modular systems for efficient, GMP-compliant production of inhaled therapies.
7. Combination Product Regulatory Strategy
Navigate FDA and EMA expectations for drug-device submissions, human factors validation, and global compliance for connected combination products.
8. Clinical Trials & Real-World Evidence
Learn to design trials with patient-centric endpoints and leverage connected devices for robust real-world data collection and post-market insights.
9. Market Access & Commercialization Pathways
Understand pricing, reimbursement, and go-to-market strategies for inhaled therapies in competitive, value-driven global healthcare markets.
10. Future of Personalized Inhalation Therapy
Explore diagnostics, biomarkers, AI tools, and inhaled vaccines enabling precision medicine and tailored respiratory treatments for diverse patient needs.
Over 25+ Sessions , several networking opportunities in a special venue chosen by our team makes this event unique and unforgettable
Members of board, C-level, Senior Vice Presidents, Vice Presidents, Directors and Heads of departments of:
5-6 November, 2025 | San Francisco, California, USA
© 2017 Copyright All Rights Reserved | Powered by EPM Group